DATA COURTESY OF 
Clinical Trials
A concentrated group of major academic and 
research institutions and research hospitals 
anchor Colorado’s clinical trial infrastructure. 
The top 10 sites account for more than 44% 
of matched clinical trial activity statewide.
Drugs
Oncology strengthened its position as a leading 
focus area, growing from 28% to more than 32% 
of the total pipeline.
1
R O C K Y  M O U N TA I N 
C A N C E R C E N T E R S
2
U N I V E R S I T Y  O F  CO LO R A D O
3
C H I L D R E N ' S  H O S P I TA L 
CO LO R A D O
4
U N I V E R S I T Y  O F 
CO LO R A D O  H O S P I TA L
5
P E N R O S E - ST.  F R A N C I S 
H E A LT H  S E R V I C E S
6
CO LO R A D O  B LO O D 
C A N C E R I N ST I T U T E
7
A DV E N T H E A LT H
8
U C H E A LT H  M E M O R I A L 
H O S P I TA L C E N T R A L
9
N O RT H  CO LO R A D O 
M E D I C A L C E N T E R
10
K A I S E R P E R M A N E N T E
D I S COV E RY  27.1%
P R E C L I N I C A L 48.1%
P H A S E 1  9.5%
P H A S E 2  7.1%
P H A S E 3  1.0%
M A R K E T E D  7.8%
Drugs By Phase
O N CO LO GY  32.2%
C E N T R A L N E R VO U S  S Y ST E M  14.2%
I N F E C T I O U S  D I S E A S E 10.5%
M E TA B O L I C D I S O R D E R S  7.8%
I M M U N O LO GY  7.1%
C A R D I OVA S C U L A R 4.8%
R E S P I R AT O RY  4.4%
A L L O T H E R 18.9%
Drugs By Specialty All Phases of Development
2026-27 BIOSCIENCE COLORADO     47

View this content as a flipbook by clicking here.